https://www.indianpharmapost.com/wanbury-q2-fy25-revenue-at-rs-1612-crore-up-116-164392024-11-16T00:00:00+05:30always0.9https://www.indianpharmapost.com/zota-health-care-q2-fy25-revenue-up-486-164402024-11-16T00:00:00+05:30always0.9https://www.indianpharmapost.com/natco-pharma-appoints-madhava-rao-karicherla-as-associate-vp-formulation-research-development-164412024-11-16T00:00:00+05:30always0.9https://www.indianpharmapost.com/ecovyst-launches-alphacat-advanced-silicas-products-for-biocatalysis-applications-164422024-11-16T00:00:00+05:30always0.9https://www.indianpharmapost.com/univar-solutions-becomes-exclusive-distributor-of-sd-head-usa-pharmaceutical-excipients-in-north-america-164432024-11-16T00:00:00+05:30always0.9https://www.indianpharmapost.com/usfda-approves-first-gene-therapy-for-treatment-of-aromatic-l-amino-acid-decarboxylase-deficiency-164442024-11-16T00:00:00+05:30always0.9https://www.indianpharmapost.com/iol-chemicals-and-pharmaceuticals-posts-q2-fy25-pt-at-rs-19-cr-164452024-11-16T00:00:00+05:30always0.9https://www.indianpharmapost.com/merck-receives-positive-eu-chmp-opinion-for-pembrolizumab-plus-chemotherapy-as-first-line-treatment-for-unresectable-non-epithelioid-mpm-164462024-11-16T00:00:00+05:30always0.9